This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Xylocaine Jelly 2% (2017-12-18)
- Starting date:
- December 18, 2017
- Posting date:
- December 21, 2017
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- Healthcare Professionals, General Public, Hospitals
- Identification number:
- RA-65506
Affected products
Xylocaine Jelly 2%
Reason
Presence of particulate matter in these lots.
Depth of distribution
Wholesalers, pharmacies, hospitals in BC, AB, NB, QC, NL, SK, ON and MB
Affected products
Xylocaine Jelly 2%
DIN, NPN, DIN-HIM
DIN 00001694
Dosage form
Gel
Strength
20 mg/ML Lidocaine Hydrochloride
Lot or serial number
- SL5082
- SM5099
- SI5048
Companies
- Recalling Firm
-
Aspen Pharmacare Canada
111 Queen St E, St 450
Toronto
Ontario
CANADA
- Marketing Authorization Holder
-
Aspen Pharmacare Canada
111 Queen St E, St 450
Toronto
Ontario
CANADA